A.Fuat KALYONCU, Nikolai KHALTAEV, Arzu YORGANCIOĞLU, Jean BOUSQUET, Ömer KALAYCI

Allerjik rinit ve astım üzerine etkisi güncelleme (ARIA 2008) Türkiye deneyimi

Bu makalede, 2008 yılında güncellenen ve yayınlanan “Allergic Rhinitis and its Impact on Asthma (ARIA)” 2008’in bir özetini yapmak ve ulusal epidemiyolojik verileri bu çalışmaya eklemek hedeflenmiştir.

Allergic rhinitis and its impact on asthma update (ARIA 2008) The Turkish perspective

In this article, it is aimed to summarize the newly updated and published version of “Allergic Rhinitis and its Impact on Asthma (ARIA) 2008” and add the recent Turkish epidemiological data on it.

PDF

___

1. Canonica GW, Bousquet J, Mullol J, et al. A survey of the burden of allergic rhinitis in Europe. Allergy 2007; 62(Suppl 85): 17-25.
2. van Oene CM, van Reij EJ, Sprangers MA, Fokkens WJ. Quality-assessment of disease-specific quality of life questionnaires for rhinitis and rhinosinusitis: A systematic review. Allergy 2007; 62: 1359-71.
3. Schatz M. A survey of the burden of allergic rhinitis in the USA. Allergy 2007; 62 (Suppl 85): 9-16.
4. Walker S, Khan-Wasti S, Fletcher M, et al. Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: Case- control study. J Allergy Clin Immunol 2007; 120: 381-7.
5. Maurer M, Zuberbier T. Under treatment of rhinitis symptoms in Europe: Findings from a cross-sectional questionnaire survey. Allergy 2007; 62: 1057-63.
6. Bousquet J, Dahl R, Khaltaev N. Global alliance against chronic respiratory diseases. Allergy 2007; 62: 216-23.
7. Bousquet J, Khaltaev N. Global surveillance, prevention and control of Chronic Respiratory Diseases. A comprehensive approach. Global Alliance against Chronic Respiratory Diseases. World Health Organization. 2007: 148.
8. Asher MI, Montefort S, Bjorksten B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006; 368: 733-43.
9. Ait-Khaled N, Odhiambo J, Pearce N, et al. Prevalence of symptoms of asthma, rhinitis and eczema in 13- to 14-year- old children in Africa: The International Study of Asthma and Allergies in Childhood Phase III. Allergy 2007;62: 247-58.
10. Pekkarinen PT, von Hertzen L, Laatikainen T, et al. A disparity in the association of asthma, rhinitis, and eczema with allergen-specific IgE between Finnish and Russian Karelia. Allergy 2007; 62: 281-7.
11. Majkowska-Wojciechowska B, Pelka J, Korzon L, et al. Prevalence of allergy, patterns of allergic sensitization and allergy risk factors in rural and urban children. Allergy 2007; 62: 1044-50.
12. Viinanen A, Munhbayarlah S, Zevgee T, et al. The protective effect of rural living against atopy in Mongolia. Allergy 2007; 62: 272-80.
13. van Ree R, Yazdanbakhsh M. Allergic disorders in African countries: Linking immunology to accurate phenotype. Allergy 2007; 62: 237-46.
14. Kalyoncu AF, Selcuk ZT, Karakoca Y, et al. Prevalence of childhood asthma and allergic diseases in Ankara, Turkey. Allergy 1994; 49: 485-8.
15. Kucukoduk S, Aydin M, Cetinkaya F, et al. The prevalence of asthma and other allergic diseases in a province of Turkey. Turk J Pediatr 1996; 38: 149-53.
16. Selcuk ZT, Caglar T, Enunlu T, Topal T. The prevalence of allergic diseases in primary school children in Edirne, Turkey. Clin Exp Allergy 1997; 27: 262-9.
17. Karaman O, Turkmen M, Uzuner N. Allergic disease prevalence in Izmir. Allergy 1997; 52: 689-90.
18. Saraclar Y, Sekerel BE, Kalayci O, et al. Prevalence of asthma symptoms in school children in Ankara, Turkey. Respir Med 1998; 92: 203-7.
19. Celik G, Mungan D, Bavbek S, et al. The prevalence of allergic diseases and atopy in Ankara, Turkey: A two-step population-based epidemiological study. J Asthma 1999; 36: 281-90.
20. Akcakaya N, Kulak K, Hassanzadeh A, et al. Prevalence of bronchial asthma and allergic rhinitis in Istanbul school children. Eur J Epidemiol 2000; 16: 693-9.
21. Turktas I, Selcuk ZT, Kalyoncu AF. Prevalence of asthmaassociated symptoms in Turkish children. Turk J Pediatr 2001; 43: 1-11.
22. Ece A, Ceylan A, Saraclar Y, et al. Prevalence of asthma and other allergic disorders among schoolchildren in Diyarbakir, Turkey. Turk J Pediatr 2001; 43: 286-92.
23. Saraclar Y, Kuyucu S, Tuncer A, et al. Prevalence of asthmatic phenotypes and bronchial hyperresponsiveness in Turkish schoolchildren: An International Study of Asth-ma and Allergies in Childhood (ISAAC) phase 2 study. Ann Allergy Asthma Immunol 2003; 91: 477-84.
24. Demir AU, Karakaya G, Bozkurt B, et al. Asthma and allergic diseases in schoolchildren: Third cross-sectional survey in the same primary school in Ankara, Turkey. Pediatr Allergy Immunol 2004; 15: 531-8.
25. Bayram I, Guneser-Kendirli S, Yilmaz M, et al. The prevalence of asthma and allergic diseases in children of school age in Adana in southern Turkey. Turk J Pediatr 2004;46: 221-5.
26. Dinmezel S, Ogus C, Erengin H, et al. The prevalence of asthma, allergic rhinitis, and atopy in Antalya, Turkey. Allergy Asthma Proc 2005; 26: 403-9.
27. Demir E, Tanac R, Can D, et al. Is there an increase in the prevalence of allergic diseases among schoolchildren from the Aegean region of Turkey? Allergy Asthma Proc 2005; 26: 410-4.
28. Ones U, Akcay A, Tamay Z, et al. Rising trend of asthma prevalence among Turkish schoolchildren (ISAAC phases I and III). Allergy 2006; 61: 1448-53.
29. Kurt E, Metintaş S, Başyiğit İ, et al. Prevalence and risk factors of allergies in Turkey (PARFAIT Study): Results of a multicentric cross-sectional study in children. Pediatr Allergy Immunol 2007; 18: 566-574.
30. Kalyoncu AF, Demir AU, Ozcakar B, et al. Asthma and allergy in Turkish university students: Two cross-sectional surveys 5 years apart. Allergol Immunopathol (Madr) 2001; 29: 264-71.
31. Kuyucu S, Saraçlar Y, Tuncer A, et al. Epidemiologic characteristics of rhinitis in Turkish children: The International Study of Asthma and Allergies in Childhood (ISAAC) phase 2. Pediatr Allergy Immunol 2006; 17:269-77.
32. Keleş N, Ilicali C. The impact of outdoor pollution on upper respiratory diseases. Rhinology 1998; 36: 24-7.
33. Keles N, Ilicali OC, Deger K. Impact of air pollution on prevalence of rhinitis in Istanbul. Arch Environ Health 1999;54: 48-51.
34. Kalyoncu AF, Stalenheim G. Survey on the allergic status in a Turkish population in Sweden. Allergol Immunopathol (Madr) 1993; 21: 11-4.
35. Kabesch M, Schaal W, Nicolai T, von Mutius E. Lower prevalence of asthma and atopy in Turkish children living in Germany. Eur Respir J 1999; 13: 577-82.
36. Hjern A, Haglund B, Hedlin G. Ethnicity, childhood environment and atopic disorder. Clin Exp Allergy 2000;30: 521-8.
37. Tobias A, Soriano JB, Chinn S, et al; European Community Respiratory Health Survey. Symptoms of asthma, bronchial responsiveness and atopy in immigrants and emigrants in Europe. European Community Respiratory Health Survey. Eur Respir J 2001; 18: 459-65.
38. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108 (5 Suppl): 147-334.
39. Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Clinical guidelines: Developing guidelines. BMJ 1999; 318: 593-6.
40. Custovic A, Wijk RG. The effectiveness of measures to change the indoor environment in the treatment of allergic rhinitis and asthma: ARIA update (in collaboration with GA(2)LEN). Allergy 2005; 60: 1112-5.
41. Passalacqua G, Bousquet PJ, Carlsen KH, et al. ARIA update: I--Systematic review of complementary and alternative medicine for rhinitis and asthma. J Allergy Clin Immunol 2006; 117: 1054-62.
42. Bonini S, Bonini M, Bousquet J, et al. Rhinitis and asthma in athletes: An ARIA document in collaboration with GA2LEN. Allergy 2006; 6: 681-92.
43. Bousquet J, van Cauwenberge P, Ait Khaled N, et al. Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GALEN). Allergy 2006; 61: 1086-96.
44. Passalacqua G, Durham SR. Allergic rhinitis and its impact on asthma update: Allergen immunotherapy. J Allergy Clin Immunol 2007; 119: 881-91.
45. Cruz AA, Popov T, Pawankar R, et al. Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN. Allergy 2007; 62 (Suppl 84): 1-41.
46. Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 2004; 24:758-64.
47. Demoly P, Allaert FA, Lecasble M, Bousquet J. Validation of the classification of ARIA (allergic rhinitis and its impact on asthma). Allergy 2003; 58: 672-5.
48. Bachert C, van Cauwenberge P, Olbrecht J, van Schoor J. Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium. Allergy 2006; 61:693-8.
49. Todo-Bom A, Loureiro C, Almeida MM, et al. Epidemiology of rhinitis in Portugal: Evaluation of the intermittent and the persistent types. Allergy 2007; 62: 1038-43.
50. Van Hoecke H, Vastesaeger N, Dewulf L, et al. Is the allergic rhinitis and its impact on asthma classification useful in daily primary care practice? J Allergy Clin Immunol 2006; 118: 758-9.
51. Valero A, Ferrer M, Sastre J, et al. A new criterion by which to discriminate between patients with moderate allergic rhinitis and patients with severe allergic rhinitis based on the Allergic Rhinitis and its Impact on Asthma severity items. J Allergy Clin Immunol 2007;120: 359-65.
52. Bousquet PJ, Combescure C, Neukirch F, et al. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy 2007; 62: 367-72.
53. Boot JD, de Kam ML, Mascelli MA, et al. Nasal nitric oxide: Longitudinal reproducibility and the effects of a nasal allergen challenge in patients with allergic rhinitis. Allergy 2007; 62: 378-84.
54. Juniper EF, Riis B, Juniper BA. Development and validation of an electronic version of the rhinoconjunctivitis quality of life questionnaire. Allergy 2007; 62: 1091-3.
55. Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, et al. Aspirin provocation tests for diagnosis of aspirin sensitivity. EAACI/GA2LEN guideline. Allergy 2007; 62:1111-8.
56. Bonini M, Lapucci G, Petrelli G, et al. Predictive value of allergy and pulmonary function tests for the diagnosis of asthma in elite athletes. Allergy 2007; 62: 1166-70.
57. Bonini S, Rasi G, Brusasco V, et al. Nonspecific provocation of target organs in allergic diseases: EAACIGA( 2)LEN consensus report. Allergy 2007; 62: 683-94.
58. Burgess JA, Walters EH, Byrnes GB, et al. Childhood allergic rhinitis predicts asthma incidence and persistence to middle age: A longitudinal study. J Allergy Clin Immunol 2007; 120: 863-9.
59. Chatkin MN, Menezes AM, Victora CG, Barros FC. High prevalence of asthma in preschool children in Southern Brazil: A population-based study. Pediatric Pulmonology 2003; 35: 296-301.
60. Giovannini M, Agostoni C, Riva E, et al. A randomized prospective double blind controlled trial on effects of long-term consumption of fermented milk containing Lactobacillus casei in pre-school children with allergic asthma and/or rhinitis. Pediatr Res 2007; 62: 215-20.
61. Viegi G, La Grutta S. Rhinoconjunctivitis and wheeze in preschool children: A different relationship than in adults (United or Coexistent Airways Disease)? Allergy 2007; 62: 344-7.
62. Choi SH, Yoo Y, Yu J, et al. Bronchial hyperresponsiveness in young children with allergic rhinitis and its risk factors. Allergy 2007; 62: 1051-6.
63. Bateman ED, Jithoo A. Asthma and allergy-a global perspective. Allergy 2007; 62: 213-5.
64. English RG, Fairall LR, Bateman ED. Keeping allergy on the agenda: Integrated guidelines for respiratory disease in developing countries. Allergy 2007; 62: 224-9.
65. Bousquet J, Khaltaev N, Cruz A, et al. ARIA Update. Allergy 2008; 63 (Suppl 86): 8-160.
66. Schunemann HJ, Hill SR, Kakad M, et al. Transparent development of the WHO rapid advice guidelines. PLoS Med 2007; 4: 119.
67. Brozek JL, Baena-Cagnani CE, Bonini S, et al. Methodology for development of the allergic rhinitis and its impact on asthma guideline 2008 update. Allergy 2008; 63:38-46.
68. Fokkens WJ, Jogi R, Reinartz S, et al. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen. Allergy 2007; 62: 1078-84.
69. Philip G, Nayak AS, Berger WE, et al. The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Curr Med Res Opin 2004 ;20: 1549-58.
70. Barnes ML, Menzies D, Fardon TC, et al. Combined mediator blockade or topical steroid for treating the unified allergic airway. Allergy 2007; 62: 73-80.
71. Durham SR, Riis B. Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockage. Allergy 2007; 62: 954-7.
72. Durham SR, Yang WH, Pedersen MR, et al. Sublingual immunotherapy with once-daily grass allergen tablets: A randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006; 117: 802-9.
73. Dahl R, Kapp A, Colombo G, et al. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006; 118: 434-40.
74. Didier A, Malling HJ, Worm M, et al. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol 2007; 120: 1338-45.
75. Canonica GW, Baena-Cagnani CE, Bousquet J, et al. Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy 2007; 62: 317-24.
76. Clark J, Schall R. Assessment of combined symptom and medication scores for rhinoconjunctivitis immunotherapy clinical trials. Allergy 2007; 62: 1023-8.
77. Casale TB, Romero FA, Spierings EL. Intranasal noninhaled carbon dioxide for the symptomatic treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 2008; 121: 105-9.
78. Molgaard E, Thomsen SF, Lund T, et al. Differences between allergic and nonallergic rhinitis in a large sample of adolescents and adults. Allergy 2007; 62: 1033-7.
79. Greiner AN, Meltzer EO. Pharmacologic rationale for treating allergic and nonallergic rhinitis. J Allergy Clin Immunol 2006; 118: 985-98.
80. Linneberg A, Jorgensen T, Nielsen NH, et al. The prevalence of skin-test-positive allergic rhinitis in Danish adults: Two cross-sectional surveys 8 years apart. The Copenhagen Allergy Study. Allergy 2000; 55: 767-72.
81. Terreehorst I, Oosting AJ, Tempels-Pavlica Z, et al. Prevalence and severity of allergic rhinitis in house dust miteallergic patients with bronchial asthma or atopic dermatitis. Clin Exp Allergy 2002; 32: 1160-5.
82. Georgy V, Fahim HI, El Gaafary M, Walters S. Prevalence and socioeconomic associations of asthma and allergic rhinitis in Cairo, Egypt. Eur Respir J 2006; 28: 756-62.
83. Antonicelli L, Micucci C, Voltolini S, et al. Allergic rhinitis and asthma comorbidity: ARIA classification of rhinitis does not correlate with the prevalence of asthma. Clin Exp Allergy 2007; 37: 954-60.
84. Antonicelli L, Micucci C, Voltolini S, et al. Relationship between ARIA classification and drug treatment in allergic rhinitis and asthma. Allergy 2007; 62: 1064-70.
85. Stelmach R, do Patrocinio TNM, Ribeiro M, Cukier A. Effect of treating allergic rhinitis with corticosteroids in patients with mild-to-moderate persistent asthma. Chest 2005; 128: 3140-7.
86. Camargos P, Ibiapina C, Lasmar L, Cruz AA. Obtaining concomitant control of allergic rhinitis and asthma with a nasally inhaled corticosteroid. Allergy 2007; 62: 310-6.
87. Jacobsen L, Niggemann B, Dreborg S, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007; 62: 943-8.
88. Civelek E, Soyer OU, Gemicioglu B, Sekerel BE. Turkish physicians’ perception of allergic rhinitis and its impact on asthma. Allergy 2006; 61: 1454-8.
89. Demoly P, Concas V, Urbinelli R, Allaert F. Evaluation de l’influence des recommandations OMS-ARIA sur la prise en charge de la rhinite allergique en pratique de ville en France. Enguête ERNANI. Rev fr Allergol Immunol Clin 2006; 46: 626-32.